Complete Up To Date Information about Finaplix -S.
NADA Number: 138-612 | |
| Proprietary Name |
Finaplix®-S Finaplix®-H |
|---|---|
| Sponsor |
Intervet, Inc. |
| Sponsor Address |
29160 Intervet Lane P.O. Box 318 Millsboro, DE 19966 USA |
| Ingredients |
Trenbolone Acetate |
| Species |
Cattle, beef, heifers fed in confinement for slaughter Cattle, beef, steers fed in confinement for slaughter |
| Routes of Administration |
Subcutaneous |
| Dose Form |
Implant (pellet) |
| Drug Form |
Implant (pellet) |
| Dispensing Status |
OTC |
| Patent Number |
3939265 |
| Withdrawal Time |
Cattle: zero days before slaughter. |
|
Dosage Amount, Indications & Limitations |
522.2476 Trenbolone acetate. Specifications: Each pellet for implanting contains 20 milligrams of trenbolone acetate. Conditions of use: Cattle (heifers fed in confinement for slaughter): Amount: 200 milligrams trenbolone acetate (10 pellets of 20 milligrams each). Use last 63 days prior to slaughter. Indications: For increased rate of weight gain and improved feed efficiency. Limitations: Implant subcutaneously in ear only. Do not use in animals intended for subsequent breeding or in dairy animals. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Cattle (steers fed in confinement for slaughter) Amount: 140 milligrams (mg) trenbolone acetate (one implant consisting of 7 pellets, each pellet containing 20 mg trenbolone acetate) per implant dose. Use last 126 days prior to slaughter. Should be reimplanted once after 63 days. Indications: For improved feed efficiency. Limitations: Implant subcutaneously in ear only. Do not use in animals intended for subsequent breeding or in dairy animals. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. |
| Tolerances |
A tolerance for total trenbolone residues in uncooked edible tissues of cattle is not needed. |